A series of in vitro and in vivo functional studies demonstrate that ACYP2 is a potent oncogene in glioma cells through promoting Ca2+ efflux and subsequently activating c-Myc and STAT3 signals. This evidence concerns the gene STAT3 and central nervous system cancer.